We are very proud to announce that our motivated CROS CRO Team had worked very hard to deliver FIH – First in Human – study in oncology. First in Human studies are part of phase I clinical trials and take place after the new treatment has been tested in laboratory.
We are determinated to deliver the highest level of QUALITY and affirm that SAFETY of our patients is FIRST. Please find the details of our new FIH oncology project:
CROS CRO Clinical trial Phase I new FIH oncology project
We thank our partners for their trust as we are very grateful for the confidence you’ve shown in us!
#adamed #research #oncology #clinicaltrials
Last posty
